Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand (GerdQ)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00999063 |
Recruitment Status
:
Completed
First Posted
: October 21, 2009
Last Update Posted
: March 31, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Upper GIT Symptoms |
Study Type : | Observational |
Actual Enrollment : | 4108 participants |
Time Perspective: | Prospective |
Official Title: | Prevalence of GERD in Patients With upperGITsymptoms in Thailand |
Study Start Date : | December 2009 |
Actual Primary Completion Date : | February 2011 |
Actual Study Completion Date : | February 2011 |

- Prevalence of gastroesophageal reflux disease (GERD) in patients presented with upper gastrointestinal tract symptoms
- Response to various treatments for patients who have been diagnosed of GERD

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Provision of informed consent prior to any study specific procedures
- Female or male aged at least 18 years
- Patient must be having symptoms suggestive of upper gastrointestinal tract symptoms such as heart burn/ regurgitation
Exclusion Criteria:
- Involvement in the planning and /or conduct of the study (applies to both AstraZeneca staff and /or staff at study site
- Participation in a clinical study(excluding non-interventional study or registry) during the last 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00999063
Thailand | |
Research Site | |
Bangkok Noi, Bangkok, Thailand | |
Research Site | |
Muang, Bangkok, Thailand | |
Research Site | |
Pathumwan, Bangkok, Thailand | |
Research Site | |
Rajthevee, Bangkok, Thailand | |
Research Site | |
Ratchthewi, Bangkok, Thailand | |
Research Site | |
Maerim, Chiang Mai, Thailand | |
Research Site | |
Maung, Chiang Mai, Thailand | |
Research Site | |
Maung, Khon Kaen, Thailand | |
Research Site | |
Maung, Nakhon Sri Thammarat, Thailand | |
Research Site | |
Maung, Nakhonratchasima, Thailand | |
Research Site | |
Maung, Nakhonsawan, Thailand | |
Research Site | |
Maung, Nakornpathom, Thailand | |
Research Site | |
Muang, Nonthaburi, Thailand | |
Research Site | |
Klong Luang, Pathumthani, Thailand | |
Research Site | |
Maung, Phetchabun, Thailand | |
Research Site | |
Maung, Phuket, Thailand | |
Research Site | |
Maung, Rajburi, Thailand | |
Research Site | |
Maung, Roiet, Thailand | |
Research Site | |
Maung, Samut sakorn, Thailand | |
Research Site | |
Maung, Sukhothai, Thailand | |
Research Site | |
Maung, Trang, Thailand | |
Research Site | |
Maung, Ubonratchathani, Thailand | |
Research Site | |
Varin Chamrap, Ubonratchathani, Thailand | |
Research Site | |
Muang, Udon Thani, Thailand | |
Research Site | |
Maung, Uttaradit, Thailand |
Principal Investigator: | Somchai Leelasukolvong, Dr. | Siriraj Hospital |
Responsible Party: | Sompob Paibulsirijit, MD, Vice President Medical& Regulatory Affairs department, AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00999063 History of Changes |
Other Study ID Numbers: |
NIS-GTH-NEX-2009/1 |
First Posted: | October 21, 2009 Key Record Dates |
Last Update Posted: | March 31, 2011 |
Last Verified: | March 2011 |
Keywords provided by AstraZeneca:
GerdQ |
Additional relevant MeSH terms:
Gastroesophageal Reflux Esophageal Motility Disorders Deglutition Disorders |
Esophageal Diseases Gastrointestinal Diseases Digestive System Diseases |